It's another busy week of earnings, and there's no shortage of setups for investors to considerBiogen (BIIB) is due to report Tuesday before the openThe headline flow has been positive in recent weeks, and the chart looks solid ahead of earningsIn particular, expectations are high for Biogen's experimental multiple sclerosis (MS) pill BG-12. Late-...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.